Stay updated on Evobrutinib Study in RMS Clinical Trial
Sign up to get notified when there's something new on the Evobrutinib Study in RMS Clinical Trial page.

Latest updates to the Evobrutinib Study in RMS Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. No study details, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page adds a Show glossary option and minor wording changes to QC-related labels (e.g., Last Update Submitted that Met QC Criteria and No FEAR Act Data) and a new revision note (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check47 days agoChange DetectedA new Locations section appears with Massachusetts listed as a site. The page revision updates to v3.3.3 and the existing Massachusetts Locations and HHS Vulnerability Disclosure entries are removed.SummaryDifference0.2%

- Check75 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check82 days agoChange DetectedThe government funding status notice was removed from the page, and it previously informed users about potential delays and directed them to cc.nih.gov and opm.gov for updates.SummaryDifference0.4%

Stay in the know with updates to Evobrutinib Study in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evobrutinib Study in RMS Clinical Trial page.